Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI) LSE:TYRU London Ordinary Share US90239R2031 COM SHS USD0.001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.10p 1.00p 1.20p 1.10p 1.10p 1.10p 0 07:50:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 4.6 -1.5 -0.7 - 1.63

Tyratech (DI) Share Discussion Threads

Showing 2626 to 2646 of 2650 messages
Chat Pages: 106  105  104  103  102  101  100  99  98  97  96  95  Older
DateSubjectAuthorDiscuss
18/8/2017
08:10
harry, I've just emailed Bruno with a suggestion he includes the following advice on the Vamousse packaging... Not suitable for 2-year-old, pregnant, breast-feeding asthmatics with a skin condition. Hope that helps.
michaelsadvfn
17/8/2017
20:00
Sorry you can't read the nice report. No doubt others can and will.just carry on pumping. I am also sorry the mcap is greater than that quoted on ADVFN and so out of reach for you to make a takeover bid . any news on the household powder being sold in France ? Is this going to get the share price back to 10p ?
haroldthegreat
17/8/2017
19:36
As they say turnover is vanity profit is sanity... In 2016 Vamousse made a net profit of $2.2m on $8m worth of sales. If the market cap is wrong why not get ADVFN to correct it... I'm not going to spell it out again and it's not my job to alter the ADVFN software to take into consideration there are 2 lines of stock. If they have 8% of the us market surely the price would have risen... That's a very naive comment coming from a self proclaimed 'intelligent professional'. As mudbath would say, sentiment can turn on a sixpence. It turned on a sixpence when the share price rose from 4.5p to 22p yet nothing about the company had changed, in fact at the time they had no sales whatsoever and the market cap reached almost £40m so don't assume there's any logic in the market. There isn't. I can't access the report as it is only available to U.K. residents. I won't comment on the rest of your input, save to say the product works and people are buying it.
michaelsadvfn
17/8/2017
18:56
You might like to read nice report hxxps://cks.nice.org.uk/head-lice#!scenario. especially Isopropyl myristate and isopropyl alcohol (Vamousse®, registered medical device) Advantages Largely physical action, so resistance is unlikely to develop. Disadvantages There is a lack of safety data on its use in pregnant or breastfeeding women or children younger than 2 years of age. CKS recommends Hedrin® Lotion for use in these groups, as it is licensed for use in these groups [ABPI Medicines Compendium, 2014]. There is a lack of trial data for use by people with skin conditions. Contains alcohol so not recommended for people with asthma. There are no published clinical trials on its use. Today the chemist and druggist has published an article on lice. Because of copyright I cannot reproduce it but it does bring up the cost of some products. With these physical products its essential to apply sufficient product and if something is expensive patients will be mean with it and it will not work.
haroldthegreat
17/8/2017
18:44
As they say turnover is vanity profit is sanity. If the market cap is wrong why not get ADVFN to correct it. If you are convinced the share is such a good buy make a takeover bid. If they have 8% of the us market surely the price would have risen rather than. It would appear you are the only person in the country that has noticed this anomaly. When the chart goes up like it's on viagra I will agree the 8% market share is profitable to the company.
haroldthegreat
17/8/2017
15:30
michaelsadvfn 17 Aug '17 - 12:11 - 2076 of 2082 0 0 Edit If Vamousse is too expensive how come it has grabbed 8% of the USA market? haroldthegreat 17 Aug '17 - 12:22 - 2077 of 2082 0 0 Because the idiots in the states have been using pesticide products that lice develop resistance to. So Tyratech saw an opportunity, offered an alternative and have taken 8% of the market. How could management have been so stupid?
michaelsadvfn
17/8/2017
12:55
What michael needs is help to get the price of this share up. Perhaps you might like to take a % of his takeover bid. I was just pointing out the prof would not help and it is obvious neither would I. Bruno could buy more shares.
haroldthegreat
17/8/2017
12:47
harry, I've already told you how to calculate the market cap., which isn't £1.63m. Do pay attention. U.K. sales were up 27% last year so people ARE prepared to pay a bit more for a natural product that actually works first time. Perhaps you're just not doing your job properly if you can't attract buyers of Vamousse; everyone else can. Upcoming results will tell us exactly how they're doing.
michaelsadvfn
17/8/2017
12:37
In fact over the years in the UK the mousse formats have been least popular in the UK.
haroldthegreat
17/8/2017
12:31
michaelsadvfn Thanks for the link. The Euromonitor Research Study conclusion was particularly relevant. "While shampoo is still the predominant product format for LCP, newer formats like sprays and mousses grew the fastest during the historic period (2012-2016). Consumers are willing to try newer product formats after experiencing shampoo LCPs that didn’t solve the problem. However, it is important to note that shampoos are expected to continue to dominate product formats through 2021 because consumers most associate shampoo with LCP treatments."
mudbath
17/8/2017
12:24
harold, The Prof NEEDS help.
chinese investor
17/8/2017
12:22
Because the idiots in the states have been using pesticide products that lice develop resistance to. We intelligent UK medical professionals stopped using them years ago.in the UK however we are not prepared to pay £15 a can x 4 to treat 4 hairy lousy people. The. share price chart says it all despite your perpetual pumping.with a bargain? Mcap of 1.63 million why don't you buy the company.? You could put your optimistic ideas to a lender who would no doubt lend you the funds to do it. Perhaps nobby would buy half to help you out. I do not think the Prof would be willing to help.
haroldthegreat
17/8/2017
12:11
Some info for harry... hTTp://www.headlice.org/news/SummaryofTrends_HeadLiceControlProducts_05.16.2017.pdf Widespread concern about pesticide-resistant “super lice” has boosted growth in pesticide-free products. Products with the pesticide-free claim command the highest retail prices, as observed in store audits. If Vamousse is too expensive how come it has grabbed 8% of the USA market? Just wondering like.
michaelsadvfn
14/8/2017
09:02
We're going nowhere without news. If U.S. infestations are back to normal levels we could be in for quite a good first half. Growth is key if they are looking to attract partners/investment. Fingers xxd.
michaelsadvfn
14/8/2017
08:07
Here We Go !
chinese investor
10/8/2017
20:50
Pathological Pettigrew will agree with you, no doubt about that, but I would wait until we hear more regarding the ongoing review before suggesting there will be substantial dilution. Neither you nor I have any idea what's on the cards. They might sell Vamousse(which I doubt), they might find a partner with deep pockets to take Vamousse forward(most likely). Neither of those options suggest there will be any dilution, in fact both would be seen as positive by the market. We will know more by next month at the latest as the first half results will be published in September. My money is on 2 partners taking stakes for providing funding, one for the AH side and one for the HH side.
michaelsadvfn
10/8/2017
20:47
mudbath - you are either an optimist, or a complete idiot. If you believe anything "michaels" says, you want your head testing.
professor pettigrew
10/8/2017
19:23
I like this little company for the contribution that vamousse is making, but they almost certainly need fresh funds and with the price so low there will be substantial dilution. Too early to invest IMO. Arthur
arthur_lame_stocks
09/8/2017
15:22
Whilst I would prefer the share price to be higher,Tyratech retains my interest and investment. As michaelsadvfn has said,lets wait for the updates for they will hopefully serve to generate some interesting discussion and potentially stimulate renewed buying.
mudbath
07/8/2017
20:29
You're absolutely fixated on michaelsadvfn. Whatever the problem, you need to desist.
corrientes
07/8/2017
18:55
Pathological Pettigrew. Needs locking up.
michaelsadvfn
Chat Pages: 106  105  104  103  102  101  100  99  98  97  96  95  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170822 09:04:37